Trials / Completed
CompletedNCT02527122
Biological Stardadization of D. Pteronyssinus and D. Farinae Allergen Extracts
Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract. Determination of the Allergenic Potency in Vivo Histamine Equivalent Units (HEP)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Inmunotek S.L. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Four concentrations of Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen extracts, together with a positive and negative control, using 10 mg/ml histamine dihydrochloride solution and a glycerinated phenol saline solution, respectively, will be tested in every patient in duplicate on the volar surface of the forearm..
Detailed description
This is an open, unblinded and non-randomized biological assay. The study design is a slight modification of the recommendations proposed by the Nordic Guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Allergen extracts |
Timeline
- Start date
- 2016-07-21
- Primary completion
- 2018-07-01
- Completion
- 2018-08-01
- First posted
- 2015-08-18
- Last updated
- 2018-08-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02527122. Inclusion in this directory is not an endorsement.